drugset
drugset / Trial / NCT00198549

Evaluation of Vitrase as an Adjuvant to Increase Absorption and Dispersion of Other Injected Anesthetics

NCT00198549 ↗

Phase 4 Completed 40 enrolled Bausch & Lomb Incorporated
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate Vitrase as an adjuvant to increase absorption and dispersion of other injected anesthetics

Timeline

Start
2004-09
Primary completion
2005-01
Completion
2005-03

Drugs

EvaluationDrugModalityDoseRoute
Subject HYALURONIDASE (OVINE) Protein / enzyme biologic — —

Indications

No indication recorded.